Skip to main content

Drugs: Misuse

Volume 485: debated on Wednesday 10 December 2008

To ask the Secretary of State for Health how many people residing in London are estimated to have used (a) Class A drugs and (b) any illegal drugs in the last year for which figures are available. (240586)

According to the 2007-08 British Crime Survey (BCS), 3.7 per cent. of the population aged 16-59 years of age in London reported use of any Class A drug in the last year and 9.2 per cent. reported use of any illicit drug in the last year. It is not possible to provide robust estimates of the number of 16 to 59-year-olds who have taken drugs in London from the BCS.

To ask the Secretary of State for Health how many drugs-related hospital admissions were recorded in London in each of the last five years. (240587)

The information requested is in the following table. The system of diagnostic codes used to classify admission to hospital does not distinguish between recreational, illicit misuse or medical use of drugs. The diagnostic codes used are listed in the following table.

Number of total admissions2006-0725,7822005-0625,1482004-0521,9382003-0418,8102002-0316,069Notes:1. Finished admission episodes: A finished admission episode is the first period of in-patient care under one consultant within one health care provider. Admissions do not represent the number of in-patients, as a person may have more than one admission within the year.2. The ICD-10 codes used to identify a drug related diagnosis are as follows. It is not possible to identify in ICD-10 all diseases caused by drugs (legal or illegal) and there is no way to guarantee, that the admission was drug related. For example, a patient admitted for inguinal hernia surgery may also be dependent on a drug.F11—Mental and behavioural disorders due to use of opioidsF12—Mental and behavioural disorders due to use of cannabinoidsF13—Mental and behavioural disorders due to use of sedatives or hypnoticsF14—Mental and behavioural disorders due to use of cocaineF15—Mental and behavioural disorders due to use of other stimulants, including caffeineF16—Mental and behavioural disorders due to use of hallucinogensF18—Mental and behavioural disorders due to use of volatile solventsF19—Mental and behavioural disorders due to multiple drug use and use of other psychoactive substancesF55—Abuse of non-dependence-producing substancesK71.0—Toxic liver disease with cholestasisK71.1—Toxic liver disease with hepatic necrosisK71.2—Toxic liver disease with acute hepatitisK71.3—Toxic liver disease with chronic persistent hepatitisK71.4—Toxic liver disease with chronic lobular hepatitisK71.5—Toxic liver disease with chronic active hepatitisK71.6—Toxic liver disease with hepatitis, not elsewhere classifiedK71.7—Toxic liver disease with fibrosis and cirrhosis of liverK71.8—Toxic liver disease with other disorders of liverK71.9—Toxic liver disease, unspecifiedT36—Poisoning by systemic antibioticsT37—Poisoning by other systemic anti-infectives and antiparasitics T38—Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classifiedT39—Poisoning by nonopioid analgesics, antipyretics and antirheumaticsT40—Poisoning by narcotics and psychodysleptics (hallucinogens)T41—Poisoning by anaesthetics and therapeutic gasesT42—Poisoning by antiepileptic, sedative-hypnotic and antiparkinsonism drugsT43—Poisoning by psychotropic drugs, not elsewhere classifiedT44—Poisoning by drugs primarily affecting the autonomic nervous systemT45—Poisoning by primarily systemic and haematological agents, not elsewhere classifiedT46—Poisoning by agents primarily affecting the cardiovascular systemT47—Poisoning by agents primarily affecting the gastrointestinal systemT48—Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory systemT49—Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolaryngological and dental drugsT50—Poisoning by diuretics and other and unspecified drugs, medicaments and biological substancesT52—Toxic effect of organic solventsT53—Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbonsT54—Toxic effect of corrosive substancesT55—Toxic effect of soaps and detergentsT56—Toxic effect of metalsT57—Toxic effect of other inorganic substancesT58—Toxic effect of carbon monoxideT59—Toxic effect of other gases, fumes and vapoursT60—Toxic effect of pesticidesT61—Toxic effect of noxious substances eaten as seafoodT62—Toxic effect of other noxious substances eaten as foodT63—Toxic effect of contact with venomous animalsT64—Toxic effect of aflatoxin and other mycotoxin food contaminantsT65—Toxic effect of other and unspecified substancesX40—Accidental poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumaticsX41—Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classifiedX42—Accidental poisoning by and exposure to narcotics and psychodysleptics (hallucinogens), not elsewhere classifiedX43—Accidental poisoning by and exposure to other drugs acting on the autonomic nervous systemX44—Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substancesX46—Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapoursX47—Accidental poisoning by and exposure to other gases and vapoursX48—Accidental poisoning by and exposure to pesticidesX49—Accidental poisoning by and exposure to other and unspecified chemicals and noxious substancesX60—Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumaticsX61—Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classifiedX62—Intentional self-poisoning by and exposure to narcotics and psychodysleptics (hallucinogens), not elsewhere classifiedX63—Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous systemX64—Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substancesX66—Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapoursX67—Intentional self-poisoning by and exposure to other gases and vapoursX68—Intentional self-poisoning by and exposure to pesticidesX69—Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substancesY40—Systemic antibioticsY41—Other systemic anti-infectives and antiparasiticsY42—Hormones and their synthetic substitutes and antagonists, not elsewhere classifiedY43—Primarily systemic agentsY44—Agents primarily affecting blood constituentsY45—Analgesics, antipyretics and anti-inflammatory drugsY46—Antiepileptic and antiparkinsonism drugsY47—Sedatives, hypnotics and antianxiety drugsY48—Anaesthetics and therapeutic gasesY49—Psychotropic drugs, not elsewhere classifiedY50—Central nervous system stimulants, not elsewhere classifiedY51—Drugs primarily affecting the autonomic nervous systemY52—Agents primarily affecting the cardiovascular systemY53—Agents primarily affecting the gastrointestinal systemY54—Agents primarily affecting water-balance and mineral and uric acid metabolismY55—Agents primarily acting on smooth and skeletal muscles and the respiratory systemY56—Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugsY57—Other and unspecified drugs and medicamentsY58—Bacterial vaccinesY59—Other and specified vaccines and biological substancesT80.0—Air embolism following infusion, transfusion and therapeutic injection T80.1—Vascular complications following infusion, transfusion and therapeutic injectionT80.2—Infections following infusion, transfusion and therapeutic injectionT80.8—Other complications following infusion, transfusion and therapeutic injectionT80.9—Unspecified complication following infusion, transfusion and therapeutic injectionT88.0—Infection following immunisationT88.1—Other complications following immunisation, not elsewhere classifiedT88.2—Shock due to anaesthesiaT88.3—Malignant hyperthermia due to anaesthesiaT88.5—Other complications of anaesthesiaT88.6—Anaphylactic shock due to adverse effect of correct drug or medicament properly administeredT88.7—Unspecified adverse effect of drug or medicamentZ71.5—Drug abuse counselling and surveillanceT96.X—Sequelae of poisoning by drugs, medicaments and biological substances3. London Strategic Health Authority of Treatment: In 2006-07 London as a whole was a strategic health authority (SHA). Pre 2006-07 London was made up of five SHAs.2006-07: London SHAPre 2006-07: North West London; North Central London; North East London; South East London; South West London4. Ungrossed Data: Figures have not been adjusted for shortfalls in data (i.e. the data are ungrossed).Source:Hospital Episode Statistics, The NHS Information Centre for health and social care